MedTrace Logo

Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy

NCT00916266 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-07-31

No results posted yet for this study

Summary

This research investigates the use of autologous bone marrow stem cells for the treatment of medically refractory temporal lobe epilepsy patients.

Conditions

Interventions

PROCEDURE

Stem cell transplantation

Transplantations with autologous bone marrow mononuclear stem cells by selective posterior cerebral artery angiography

Sponsors & Collaborators

  • Hospital Sao Lucas da PUCRS

    collaborator OTHER

  • Instituto do Cerebro da PUCRS

    collaborator UNKNOWN

  • Instituto do Cerebro de Brasilia

    lead OTHER

Principal Investigators

  • Jaderson C da Costa, MD, PhD · Instituto do Cerebro-PUCRS

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-11-30
Completion
2012-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00916266 on ClinicalTrials.gov